Assignee
SHENZHEN YANDAI INVEST CO LTD
CN·1 granted patent·3 pending applications·0 citations·filing 2025–2025
Top patents by PatentIndex Score
4 records- 0143US2025144131A1Polysaccharide compound with a defined molecular structure for the treatment of pulmonary fibrosisSHENZHEN YANDAI INVEST CO LTD·Filed 2025·Application pending·0 cites
- 0228US2025144132A1Polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugsSHENZHEN YANDAI INVEST CO LTD·Filed 2025·Application pending·0 cites
- 0326US12383577B2Polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugsSHENZHEN YANDAI INVEST CO LTD·Filed 2025·Granted Aug 12, 2025·0 cites·13 claims
- 0426US2025144130A1Polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugsSHENZHEN YANDAI INVEST CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENZHEN YANDAI INVEST CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →